Scholarly Index
Kevin Biglan
Eli Lilly (United States); 12,143 total citations; 124 total publications; best world rank #258
Eli Lilly (United States)
12,143Total citations
124Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 978 | US 336 | 97.10 |
| Genetic Neurodegenerative Diseases | Lifetime | 738 | US 286 | 96.25 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 964 | US 351 | 96.55 |
| Telemedicine and Telehealth Implementation | Lifetime | 258 | US 126 | 94.87 |
| Assistive Technology in Communication and Mobility | Lifetime | 850 | US 387 | 84.75 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 643 | US 52 | 44.08 |